Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability
The Journal of Clinical Endocrinology & Metabolism · 19.05.2026 · 111 (6) · e1626-e1633
DOI: 10.1210/clinem/dgaf675 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 17.12.2025. Verfasst von Matthew D Ettleson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Thyroxine, Blood Pressure, Hypothyroidism, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Diabetes Research and Training Center, Chicago Center for Diabetes Translation Research, Career Development Program.
Abstract (Originalsprache)
Context
Thyroid hormone homeostasis is critical to the metabolic function of cardiovascular tissues. The degree to which the suboptimal treatment of hypothyroidism with levothyroxine (LT4) impacts blood pressure (BP) and blood pressure variability (BPV) is not known.
Objectives
Determine the relationship between LT4 time above range (TAR) (TSH level >4.5 mIU/L), time below range (TBR) (TSH <0.4 mIU/L), and changes in annual mean systolic (SBP) and diastolic blood pressure (DBP) and visit-to-visit BPV.
Methods
Using longitudinal data from 2203 adult patients treated with LT4, we modeled within-individual changes in annual mean BP and BPV as a function of TAR and TBR (% time). Linear mixed-effect modeling was utilized to allow for differences in observation time between patients. Models were adjusted for sociodemographics, baseline comorbidities, weight, LT4 dose, time, and year of study enrollment. Sensitivity analyses were conducted with wide in-range boundaries (TSH 0.1-10 mIU/L) and stratification by hypertension at baseline.
Results
In the primary modeling, a 100% increase in TAR was associated with significant increases in annual mean SBP and DBP (+1.8 mmHg, P = .011; +1.0 mmHg, P = .024, respectively). Similarly, a 100% increase in TBR was associated with increases in annual mean SBP and DBP (+2.7 mmHg, P = .004; +1.3 mmHg, P = .034, respectively). However, the expected differences in BP with TAR and TBR diminished in subsequent years. One hundred percent TAR and TBR were associated with small increases in annual visit-to-visit diastolic BPV (+0.67 mmHg, P = .009; +0.85 mmHg, P = .020, respectively).
Conclusion
Suboptimal LT4 treatment was associated with increases in mean BP and BPV, representing potential mediators in the pathway between suboptimal LT4 treatment and cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637, USA.
- Section of General Internal Medicine, University of Chicago, Chicago, IL 60637, USA.
- Department of Public Health Sciences, University of Chicago, Chicago, IL 60637, USA.
- Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Division of Endocrinology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.
ORCID-Profile: Matthew D Ettleson, Neda Laiteerapong
Förderung
- Diabetes Research and Training Center
- Chicago Center for Diabetes Translation Research
- Career Development Program
- NIA NIH HHS
- National Institute of Diabetes and Digestive and Kidney Disease
- NIDDK NIH HHS
- NIH HHS
- University of Chicago
Zitieren
APA
Ettleson, M. D., Thomas, N., Wan, W., Hedeker, D., Cappola, A. R., Laiteerapong, N., & Bianco, A. C. (2026). Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability. The Journal of Clinical Endocrinology & Metabolism, 111(6), e1626-e1633. https://doi.org/10.1210/clinem/dgaf675
Vancouver
Ettleson MD, Thomas N, Wan W, Hedeker D, Cappola AR, Laiteerapong N, et al. Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability. The Journal of Clinical Endocrinology & Metabolism. 2026;111(6):e1626-e1633. doi:10.1210/clinem/dgaf675
BibTeX
@article{Ettleson2026,
author = {Ettleson, Matthew D and Thomas, Nikita and Wan, Wen and Hedeker, Donald and Cappola, Anne R and Laiteerapong, Neda and Bianco, Antonio C},
title = {Suboptimal Levothyroxine Treatment is Associated with Increases in Mean Blood Pressure and Blood Pressure Variability},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
volume = {111},
number = {6},
pages = {e1626--e1633},
doi = {10.1210/clinem/dgaf675}
}
EUVIMED